THE UK Medicines and
Healthcare Product Regulatory
Agency has said that cold and flu
remedies containing
pseudoephedrine and ephedrine
will remain as pharmacy (P)
medicines.
The announcement comes on
the back of a review of measures
taken in 2007, which saw
pseudoephedrine and ephedrine
cold and flu meds moved to
pharmacy only, in order to cut
down on the misuse of the drugs.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.